Amit Bhalla - 30 Jun 2021 Form 4 Insider Report for NAVIDEA BIOPHARMACEUTICALS, INC.

Role
Director
Signature
/s/ Jed A. Latkin for Amit Bhalla, by power of attorney
Issuer symbol
N/A
Transactions as of
30 Jun 2021
Net transactions value
$0
Form type
4
Filing time
07 Jul 2021, 17:42:32 UTC
Next filing
01 Oct 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NAVB Common Stock Award $0 +2,409 +96% $0.000000 4,909 30 Jun 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock issued under the Amended and Restated 2014 Stock Incentive Plan in partial payment of quarterly non-employee director fees.